Paul Matteis' Stock Ratings

Stifel Analyst

Paul Matteis is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/20/2024

Overall Average Return

-9.88%

Smart Score

43.4%

Overall Average Return Percentile

20th

Number of Ratings

135
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Where Sage Therapeutics Stands With Analysts
Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
The Latest Analyst Ratings For Biomarin Pharmaceutical
The Analyst Landscape: 29 Takes On Biomarin Pharmaceutical
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
A Glimpse Into The Expert Outlook On Alkermes Through 9 Analysts
In-Depth Examination Of 29 Analyst Recommendations For Biomarin Pharmaceutical
Analyst Expectations For Biomarin Pharmaceutical's Future
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (14 Ratings)
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved